Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain

E-ISSN： 1875-533x|25|32|3866-3882

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.25, Iss.32, 2018-10, pp. : 3866-3882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting cannabinoid agonists for inflammatory and neuropathic pain

By Cheng Yuan Hitchcock Stephen A

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-07 ,pp. : 951-965

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Management of Neuropathic Pain

By McCleane G.

CNS Drugs, Vol. 17, Iss. 14, 2003-01 ,pp. : 1031-1043

Adis International

Access to resources Recommend Favorite

Targeting Voltage-Gated Sodium Channels for Treating Neuropathic and Inflammatory Pain

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. : 1715-1719

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Treatment of Diabetic Neuropathic Pain

By Smith Howard S.

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 557-589

Adis International

Access to resources Recommend Favorite

Pharmacological strategies in relieving neuropathic pain

By McCleane Gary

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1299-1312

Informa Healthcare

Access to resources Recommend Favorite